Koyfin Home > Directory > Health Care > LA Jolla Pharma > EV / EBITDA (ltm)

LA Jolla Pharma EV / EBITDA (ltm) Chart (LJPC)

LA Jolla Pharma annual/quarterly EV / EBITDA (ltm) from 2010 to 2011. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • LA Jolla Pharma EV / EBITDA (ltm) for the quarter ending May 05, 2011 was 2.00 a -1.20% decrease of -0.02 year over year
  • LA Jolla Pharma EV / EBITDA (ltm) for the last 12 months ending May 05, 2011 was 2.00 a -1.20% decrease of -0.02 year over year
  • LA Jolla Pharma Annual EV / EBITDA (ltm) for 2011 was 2.00 a -0.71% decrease of -0.01 from 2010
  • LA Jolla Pharma Annual EV / EBITDA (ltm) for 2011 was 2.01 a -0.06% decrease of 0.00 from 2010
  • LA Jolla Pharma Annual EV / EBITDA (ltm) for 2011 was 2.01 a -0.43% decrease of -0.01 from 2010
Other Valuation Metrics:
  • LA Jolla Pharma Market Cap for the quarter ending March 03, 2018 was $777m a 15.21% increase of 118m year over year
  • LA Jolla Pharma Price / Book for the quarter ending March 03, 2018 was 8.09 a 47.74% increase of 3.86 year over year
  • LA Jolla Pharma Enterprise Value for the quarter ending March 03, 2018 was $692m a 27.38% increase of 190m year over year
View Chart On Koyfin

Quarterly LJPC EV / EBITDA (ltm) Data

05/20112.00
05/20112.01
05/20112.01
05/20112.02
05/20112.03
05/20112.03
05/20112.03
05/20112.02
05/20112.02
05/20111.97

Annual LJPC EV / EBITDA (ltm) Data

20112.00
20112.01
20112.01
20112.02
20112.03
20112.03
20112.03
20112.02
20112.02
20111.97